title: Linear IgA bullous dermatosis induced by angiotensin receptor antagonists.
authors.forename: Carmen
authors.initials: C
authors.lastname: Peña-Penabad
authors.forename: Jesús
authors.initials: J
authors.lastname: Rodríguez-Lozano
authors.forename: Jesús
authors.initials: J
authors.lastname: del Pozo
authors.forename: Jesús
authors.initials: J
authors.lastname: García-Silva
authors.forename: Eduardo
authors.initials: E
authors.lastname: Fonseca
mesh_terms: D000368:Aged; D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D001713:Biphenyl Compounds; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007070:Immunoglobulin A / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000276:immunology; D013777:Tetrazoles / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D057911:Angiotensin Receptor Antagonists; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D007070:Immunoglobulin A; D013777:Tetrazoles; C081643:candesartan